Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02877 SHINEWAY PHARM
RTNominal down9.100 -0.130 (-1.408%)
Others

31/10/2019 17:25

Shineway Pharma (02877) 9-month turnover up 4.6%

[ET Net News Agency, 31 October 2019] China Shineway Pharmaceutical Group Limited
(02877) said the turnover of the group for the nine months ended 30 September 2019 reached
RMB2,050 million, representing an increase of 4.6% as compared with the same period of
2018.
Turnover of injection products decreased by 7.1% to RMB953 million. Turnover of soft
capsule products increased by 5.7% to RMB351 million. Turnover of granule products
decreased by 3.4% to RMB259 million. Turnover of TCM formula granule products increased by
67.6% to RMB377 million. Turnover of products in other forms increased by 1.9% to RMB110
million. (RC)

Back to Others

Remark: Real time quote last updated: 19/04/2024 14:08
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.